Can stem cells repair a scarred liver? new trial hopes so

NCT ID NCT04357600

ENROLLING_BY_INVITATION Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial is testing whether stem cells from donated umbilical cords can help people with liver cirrhosis caused by hepatitis B. The study will give 12 patients an intravenous infusion of these stem cells and monitor their liver function, Child-Pugh score, and MELD score over six months. The goal is to see if the treatment can improve liver health and reduce the severity of cirrhosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord stem cells
What this could lead to: If it works, this could point toward a new way to manage liver cirrhosis caused by hepatitis B, potentially reducing the need for a liver transplant.
What could go wrong: This is a very small, early-phase trial with only 12 participants. It is not yet proven to work, and there may be unknown risks from the stem cell infusion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER CIRRHOSES

Contacts and locations

Locations

Cipto Mangunkusumo hospital

Jakarta, DKI Jakarta, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.